Mind Medicine Australia Clinic and Centre of Excellence is a leading centre for the treatment of Post-Traumatic Stress Disorder (PTSD) and Treatment-Resistant Depression (TRD).

We provide access to evidence-based, next-generation therapies for patients who have not achieved sufficient benefit from existing treatment options. Our work is guided by rigorous clinical protocols, a multidisciplinary team of experienced clinicians, and a commitment to delivering the best possible patient outcomes.

The clinic’s innovative cost structure will support the scalable delivery of psychedelic-assisted therapies, while ensuring these treatments remain accessible to Australian patients who could benefit from them.

Who We Are

Mind Medicine Australia Clinic is a collaborative venture between:

  • Mind Medicine Australia – a registered charity and the nation’s leading not-for-profit organisation advocating for safe and effective use of medicinal psilocybin- and MDMA-assisted therapies. Mind Medicine Australia hosts events, including a free webinar series with world-class experts, sharing insights into innovative mental health treatment options.
  • Psychennex – an Australian subsidiary of Incannex Healthcare Ltd (NASDAQ: IHL), conducting clinical trials into psychedelic-assisted therapy and advancing the scientific evidence base in Australia.

Our Approach to Care

We deliver a comprehensive model of care that goes beyond standalone pharmaceutical interventions. Each patient’s treatment pathway is:

  • Individually assessed and tailored
  • Delivered within a structured, multidisciplinary framework
  • Supported by highly trained clinical staff across psychiatry, psychology, and allied health
  • Grounded in best-practice, evidence-based protocols
  • Designed to promote safe, effective, and lasting therapeutic outcomes

Our integrated approach ensures that patients receive not only access to new treatment modalities, but also comprehensive psychological support throughout the process.

Why This Matters

Australia is experiencing an accelerating mental health crisis.

For many individuals, conventional treatments for PTSD and depression are insufficient.

Our Core Priorities

  • Safety and effectiveness in every stage of care
  • Rigorous clinical governance and staff training
  • Patient-centred outcomes, focused on lasting positive change
  • Improved accessibility and affordability through evaluation, subsidies, and advocacy for reimbursement including through Mind Medicine Australia’s Patient Support Fund